If you have diabetes, taking steps to manage it can help prevent related health issues, including MASH. Here’s what to know to protect your liver.

Grade 3 fatty liver is a serious condition which means a lot of fat buildup in the liver and it may cause serious ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

If you have obesity, losing even a little weight helps not only improve your overall health, but also prevent liver issues such as MASH.

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with ...

The health problem comes in four stages ― steatosis, where a harmless level of fat is deposited in the liver; steatohepatitis ...

Akero reported Monday strong results showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused ...

Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week ...

After missing the primary endpoint in the Phase IIb SYMMETRY trial, Akero Therapeutics’ lead molecule, efruxifermin, showed ...

Akero Therapeutics announced statistically significant results from a Phase 2b trial of efruxifermin this week, a fibroblast ...

On Monday, at 10:23 a.m. GMT-5, Akero Therapeutics ( AKRO, Financials) saw its stock soar by 106.63%, closing at $54.10, ...